Haemonetics Corporation (HAE) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $124.64 +3.62%
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Haemonetics Corporation (NYSE: HAE) reported Q3 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $231.8 million versus the consensus estimate of $234.85 million.
For earnings history and earnings-related data on Haemonetics Corporation (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
- UBS Reiterates Buy Rating on 3M (MMM)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
